Original Article
Subject Categories: Melanocytes/Melanoma
Journal of Investigative Dermatology (2006) 126, 1111–1118. doi:10.1038/sj.jid.5700173; published online 2 February 2006
Mice Transgenic for KitV620A: Recapitulation of Piebaldism but not Progressive Depigmentation Seen in Humans with this Mutation
Hiroko Tosaki1, Takahiro Kunisada2, Tsutomu Motohashi2, Hitomi Aoki2, Hisahiro Yoshida3 and Yasuo Kitajima1
- 1Department of Dermatology, Gifu University School of Medicine, Gifu, Japan
- 2Department of Tissue and Organ Development, Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Gifu, Japan
- 3Laboratory for Immunogenetics, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan
Correspondence: Professor Takahiro Kunisada, Department of Dermatology, Gifu University School of Medicine, Gifu 501-1194, Japan. E-mail: tkunisad@cc.gifu-u.ac.jp
Received 27 June 2005; Revised 18 November 2005; Accepted 8 December 2005; Published online 2 February 2006.
Abstract
Piebaldism is an autosomal dominant genetic pigmentary disorder, characterized by congenital white hair and patches located on the forehead, anterior trunk, and extremities. Most piebald patients have a mutation of the KIT gene, which encodes a tyrosine kinase receptor involved in pigment cell development. The white hair and patches of such patients are already completely formed at birth and do not usually expand thereafter. This stability of pigmented spots also applies to KitW and KitlSl mutant mice. However, two novel cases of piebaldism were reported in 2001, in which both mother and daughter having a novel Val620Ala mutation in their KIT gene showed progressive depigmentation. To prepare an animal model of this mutation, to explore undefined functions of KIT signaling for maintaining pigmented melanocytes in the skin or more specifically the integrity of the melanocyte stem cell system in the postnatal skin, we produced transgenic mice expressing Val620Ala Kit. These mice well mimicked the white spotting pattern of patients; however, no change in this pattern was observed after birth, even after increasing the transgene expression by various means. Here, we report the unexpectedly extremely stable maintenance of the melanocyte stem cell system under stringent conditions for KIT signaling.
Abbreviations:
ACK2, anti-c-kit monoclonal antibody; MT-I, metallothionein-I; SLF, steel factor; Tg, transgenic
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Adoptive transfer of nuclear factor-&kgr;B?inactive macrophages to the glomerulusKidney International Trade News
The gene mutated in bare patches and striated mice encodes a novel 3β-hydroxysteroid dehydrogenaseNature Genetics Letter (01 Jun 1999)
Novel Mutations of the KIT (Mast/Stem Cell Growth Factor Receptor) Proto-Oncogene in Human PiebaldismJournal of Investigative Dermatology Original Article
Analysis of KIT, SCF, and Initial Screening of SLUG in Patients with PiebaldismJournal of Investigative Dermatology Letter
See all 48 matches for Research


